Benzoyl peroxide
Acanya, Benzamycin, Duac, Epiduo, Epsolay, Onexton, Twyneo (benzoyl peroxide) is a small molecule pharmaceutical. Benzoyl peroxide was first approved as Benzamycin on 1984-10-26. It is used to treat acne vulgaris and rosacea in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
|---|---|
| skin and connective tissue diseases | D017437 |
Trade Name
FDA
EMA
Epsolay
CombinationsAcanya, Benzamycin, Duac, Epiduo, Onexton, Twyneo (generic drugs available since 2009-08-11, discontinued: Aktipak, Benzaclin)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Adapalene
+
Benzoyl peroxide
Benzoyl peroxide
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| EPSOLAY | Galderma | N-214510 RX | 2022-04-22 | 1 products, RLD, RS |
Benzoyl peroxide
+
Clindamycin phosphate
Benzoyl peroxide
+
Erythromycin
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| BENZAMYCIN | Bausch Health Companies | N-050557 RX | 1984-10-26 | 1 products, RLD, RS |
Show 1 discontinued
Benzoyl peroxide
+
Tretinoin
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| TWYNEO | Galderma | N-214902 RX | 2021-07-26 | 1 products, RLD, RS |
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| acanya | New Drug Application | 2020-09-30 |
| benzaclin | New Drug Application | 2017-02-16 |
| benzamycin | New Drug Application | 2020-11-30 |
| epiduo forte | New Drug Application | 2019-11-26 |
| epsolay | New Drug Application | 2022-09-15 |
| onexton | New Drug Application | 2020-04-06 |
| twyneo | New Drug Application | 2022-03-15 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| acne vulgaris | EFO_0003894 | D000152 | L70 |
| rosacea | — | D012393 | L71 |
Agency Specific
FDA
EMA
Expiration | Code | ||
|---|---|---|---|
BENZOYL PEROXIDE, EPSOLAY, GALDERMA LABS LP | |||
| 2025-04-22 | NP | ||
BENZOYL PEROXIDE / TRETINOIN, TWYNEO, GALDERMA LABS LP | |||
| 2024-07-26 | NC | ||
BENZOYL PEROXIDE / CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE, ENCUBE | |||
| 2023-03-13 | CGT | ||
Patent Expiration
Patent | Expires | Flag | FDA Information |
|---|---|---|---|
| Benzoyl Peroxide, Epsolay, Galderma Labs Lp | |||
| 11628155 | 2040-12-27 | U-3356 | |
| 11426378 | 2040-08-18 | U-3356 | |
| 10933046 | 2040-02-19 | DP | U-3357 |
| 10945987 | 2040-02-19 | U-3356 | |
| 11541026 | 2040-02-19 | U-3356 | |
| 9687465 | 2032-11-27 | DP | U-3356 |
| 9868103 | 2028-08-08 | DP | U-3194, U-3356 |
| Benzoyl Peroxide / Tretinoin, Twyneo, Galderma Labs Lp | |||
| 10420743 | 2038-07-12 | U-3194 | |
| 10653899 | 2030-12-30 | DP | U-3194 |
| 11071878 | 2030-12-30 | DP | |
| 8617580 | 2028-02-03 | DP | |
| Benzoyl Peroxide / Clindamycin Phosphate, Acanya, Bausch | |||
| 8288434 | 2029-08-05 | DP | U-124, U-134, U-818, U-916, U-921, U-1033 |
| 8663699 | 2029-06-03 | U-124 | |
| 8895070 | 2029-06-03 | U-124 | |
| 9078870 | 2029-06-03 | DP | |
| 9504704 | 2029-06-03 | DP | U-124, U-134, U-818, U-916 |
| 9561208 | 2029-06-03 | DP | U-916 |
| 10137142 | 2029-06-03 | DP | U-916 |
| 10220049 | 2029-06-03 | DP | U-916 |
| 10624918 | 2029-06-03 | U-916 | |
| Adapalene / Benzoyl Peroxide, Epiduo, Galderma Labs Lp | |||
| 8071644 | 2027-07-18 | DP | U-1078 |
| 8080537 | 2027-07-18 | U-1078 | |
| 8129362 | 2027-07-18 | U-1078 | |
| 8445543 | 2027-07-12 | U-1078 | |
| 7820186 | 2025-11-23 | DP | |
| 7964202 | 2024-09-01 | DP | U-1078 |
| Adapalene / Benzoyl Peroxide, Epiduo Forte, Galderma Labs | |||
| 8703820 | 2023-03-12 | U-1078 | |
| 8729127 | 2023-03-12 | U-1078 | |
| 9381179 | 2023-03-12 | U-1078 | |
| 9387187 | 2023-03-12 | U-1078 | |
HCPCS
No data
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | BENZOYL PEROXIDE |
| INN | — |
| Description | Benzoyl peroxide is a carbonyl compound. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | O=C(OOC(=O)c1ccccc1)c1ccccc1 |
Identifiers
| PDB | — |
| CAS-ID | 94-36-0 |
| RxCUI | 1418 |
| ChEMBL ID | CHEMBL1200370 |
| ChEBI ID | 82405 |
| PubChem CID | 7187 |
| DrugBank | DB09096 |
| UNII ID | — |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:

Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 3,941 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions

Mock data
Subscribe for the real data
Subscribe for the real data
1 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more
